Identification of novel tumour-associated antigens in canine mammary gland tumour

2013 ◽  
Vol 13 (3) ◽  
pp. 194-202 ◽  
Author(s):  
M. Furuya ◽  
M. Funasaki ◽  
H. Tani ◽  
K. Sasai
Keyword(s):  
Mammary Gland ◽  
Tumour Associated Antigens ◽  
Canine Mammary Gland ◽  
Gland Tumour

Phenotypic screening of a library of compounds against metastatic and non-metastatic clones of a canine mammary gland tumour cell line

2015 ◽  
Vol 205 (2) ◽  
pp. 288-296 ◽  
Author(s):  
K. Saeki ◽  
M. Watanabe ◽  
M. Michishita ◽  
M. Tsuboi ◽  
S. Sugano ◽  
...  
Keyword(s):  
Mammary Gland ◽  
Cell Line ◽  
Tumour Cell ◽  
Tumour Cell Line ◽  
Phenotypic Screening ◽  
Canine Mammary Gland ◽  
Gland Tumour

Mast cells in canine mammary gland tumour: number, distribution and EPOR positivity

2011 ◽  
Vol 9 (4) ◽  
pp. 310-315 ◽  
Author(s):  
A. Sfacteria ◽  
G. Lanteri ◽  
G. Grasso ◽  
B. Macrì ◽  
G. Mazzullo
Keyword(s):  
Mammary Gland ◽  
Mast Cells ◽  
Number Distribution ◽  
Canine Mammary Gland ◽  
Gland Tumour

Expression of Tumour Endothelial Marker 8 in Canine Mammary Gland Tumour Cells

2019 ◽  
Vol 173 ◽  
pp. 30-40
Author(s):  
S. Noguchi ◽  
M. Araki ◽  
K. Nakajima ◽  
M. Koh ◽  
Y. Kokado ◽  
...  
Keyword(s):  
Mammary Gland ◽  
Tumour Cells ◽  
Canine Mammary Gland ◽  
Gland Tumour ◽  
Endothelial Marker

L-type amino acid transporter 1 (LAT1): A new therapeutic target for canine mammary gland tumour

2013 ◽  
Vol 198 (1) ◽  
pp. 164-169 ◽  
Author(s):  
Shinya Fukumoto ◽  
Kiwamu Hanazono ◽  
Takahiro Komatsu ◽  
Hiroshi Ueno ◽  
Tsuyoshi Kadosawa ◽  
...  
Keyword(s):  
Mammary Gland ◽  
Amino Acid ◽  
Therapeutic Target ◽  
Amino Acid Transporter ◽  
Acid Transporter ◽  
Canine Mammary Gland ◽  
Gland Tumour

Anti-tumour effect of metformin in canine mammary gland tumour cells

2015 ◽  
Vol 205 (2) ◽  
pp. 297-304 ◽  
Author(s):  
K. Saeki ◽  
M. Watanabe ◽  
M. Tsuboi ◽  
S. Sugano ◽  
R. Yoshitake ◽  
...  
Keyword(s):  
Mammary Gland ◽  
Tumour Cells ◽  
Canine Mammary Gland ◽  
Gland Tumour ◽  
Anti Tumour Effect

scholarly journals Canine pyometra associated with Bacillus species: a case report

2018 ◽  
Vol 63 (No. 3) ◽  
pp. 143-149 ◽  
Author(s):  
MK Kim ◽  
HY Yoon ◽  
MH Lee ◽  
JH Kim
Keyword(s):  
Mammary Gland ◽  
Case Report ◽  
Bacillus Megaterium ◽  
Fatal Outcome ◽  
Bacillus Species ◽  
Bacterial Isolation ◽  
Sonographic Examination ◽  
First Time ◽  
Gland Tumour ◽  
Unilateral Mastectomy

An 11-year-old, female Maltese was presented for evaluation of a mammary gland tumour. An abdominal sonographic examination showed an echogenic, fluid-filled, dilated uterus; pyometra was also diagnosed. Ovariohysterectomy and unilateral mastectomy was performed and the dog recovered uneventfully. However, 11 h later, the dog’s condition suddenly deteriorated and it died on the day after the surgery. Bacillus circulans and Bacillus megaterium were isolated from its uterine content; these species had not been reported previously in canine pyometra. The two species were resistant to various antibiotics, including cefazolin used during the treatment. We describe for the first time the presentation, diagnosis, bacterial isolation and fatal outcome of B. circulans and B. megaterium infection in a Maltese dog with pyometra.

scholarly journals Combined detection of CA15-3, CEA, and SF in serum and tissue of canine mammary gland tumor patients

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Yuying Fan ◽  
Xiaoli Ren ◽  
Xuesong Liu ◽  
Dongmei Shi ◽  
Enshuang Xu ◽  
...  
Keyword(s):  
Mammary Gland ◽  
Malignant Tumor ◽  
Reference Value ◽  
Detection Sensitivity ◽  
Control Group ◽  
Tumor Group ◽  
Increased Sensitivity ◽  
Sensitivity Specificity ◽  
Canine Mammary Gland ◽  
Combined Detection

AbstractThe purpose of this study is to evaluate the levels and clinical diagnosis value of CA15-3, CEA, and SF in canine mammary gland tumors (CMGTs). In this study, the levels of tissues/serum CA15-3, CEA, and SF in 178 CMGT patients or healthy dogs were determined by ELISA and qRT-PCR assay. CA15-3, CEA, and SF levels of the malignant tumor group were significantly higher than that of the benign tumor group and the healthy control group. In the malignant tumor group, CA15-3 held a sensitivity of 51.8%, a specificity of 93.9%, and an accuracy of 76.8%. The sensitivity, specificity, and accuracy of CEA were 44.6%, 84.1%, and 68.1% respectively. SF held a sensitivity of 62.5%, a specificity of 85.4%, and an accuracy of 76.1%. SF showed the highest sensitivity and CA15-3 showed the highest specificity. The sensitivity, specificity, and accuracy of the combined detection of the three biomarkers in malignant tumor groups were 80.4%, 78.0%, and 80.0%, respectively, therefore combined detection increased sensitivity and accuracy but decreased specificity. In conclusion, the combined detection of serum/tissue markers CA15-3, CEA, and SF may improve the detection sensitivity of CMGTs, providing reference value for clinical application.

scholarly journals Expression and significance of CHIP in canine mammary gland tumors

2015 ◽  
Vol 77 (11) ◽  
pp. 1465-1471
Author(s):  
Huanan WANG ◽  
Xu YANG ◽  
Yipeng JIN ◽  
Shimin PEI ◽  
Di ZHANG ◽  
...  
Keyword(s):  
Mammary Gland ◽  
Mammary Gland Tumors ◽  
Canine Mammary Gland
Sign in / Sign up

Export Citation Format

Share Document